Evidence map›Paper›PMID 28236767›Full record

ArticleRedox biology2017

Triggering autophagic cell death with a di-manganese(II) developmental therapeutic.

Creina Slator, Zara Molphy, Vickie McKee, Andrew Kellett

Open access · goldAbstract readComparative Study
In one paragraph

Article in Redox biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. CopperMolecules (Basel, Switzerland) · 2019
    Article
  7. Article
  8. Article
  9. Article
  10. [Cu(TPMA)(Phen)](ClOACS omega · 2018
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Creina SlatorSchool of Chemical Sciences and National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin 9, Ireland.
Zara MolphySchool of Chemical Sciences and National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin 9, Ireland.
Vickie McKeeSchool of Chemical Sciences and National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin 9, Ireland.
Andrew KellettSchool of Chemical Sciences and National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin 9, Ireland. Electronic address: andrew.kellett@dcu.ie.
Dublin City University · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is an unmet need for novel metal-based chemotherapeutics with alternative modes of action compared to clinical agents such as cisplatin and metallo-bleomycin. Recent attention in this field has focused on designing intracellular ROS-mediators as powerful cytotoxins of human cancers and identifying potentially unique toxic mechanisms underpinning their utility. Herein, we report the developmental di-manganese(II) therapeutic [Mn

Indexed as

Antineoplastic AgentsAutophagosomesAutophagyCell Line, TumorCell SurvivalCircular DichroismDoxorubicinDrug Screening Assays, AntitumorHumansHydroxamic AcidsManganeseMitochondriaMolecular StructureNeoplasmsOrganometallic CompoundsReactive Oxygen SpeciesAntineoplastic AgentsDoxorubicinHydroxamic AcidsManganese(Mn2(mu-oda)(phen)4(H2O)2)(Mn2(mu-oda)(phen)4(oda)2) 4H2OOrganometallic CompoundsReactive Oxygen SpeciesVorinostatApoptosisAutophagyCancerManganeseSuperoxide

Identifiers

PMID28236767
PMCPMC5328722
OpenAlexW2584407667

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.